Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Other Long-Term Liabilities

v3.5.0.2
Accrued Expenses and Other Long-Term Liabilities
6 Months Ended
Jun. 30, 2016
Payables and Accruals [Abstract]  
Accrued Expenses and Other Long-Term Liabilities
9. Accrued Expenses and Other Long-Term Liabilities
 
Accrued expenses and other long-term liabilities consisted of the following:
 
 
 
June 30,
 
December 31,
 
($ in thousands)
 
2016
 
2015
 
Accrued expenses:
 
 
 
 
 
 
 
Professional fees
 
$
650
 
$
382
 
Salaries, bonuses and related benefits
 
 
1,566
 
 
2,492
 
Ovamed manufacturing rights - short term component
 
 
1,987
 
 
1,500
 
Research and development
 
 
1,018
 
 
810
 
Dr. Falk Pharma milestone
 
 
2,776
 
 
2,717
 
Accrued royalty and coupons
 
 
309
 
 
-
 
Lease impairment
 
 
146
 
 
146
 
Other
 
 
431
 
 
523
 
Total accrued expenses
 
$
8,883
 
$
8,570
 
 
 
 
 
 
 
 
 
Other long-term liabilities:
 
 
 
 
 
 
 
Deferred rent and long-term lease abandonment charge
 
 
3,706
 
 
584
 
Total other long-term liabilities
 
$
3,706
 
$
584